SCHEMBL12964396

SCHEMBL12964396

Fc1ccc(-c2nc(C(F)(F)F)nc(-n3cnc(-c4ccccc4)c3)c2-c2cccc(S)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
TDP1 Q9NUW8 3/20 0.38
HSP90AA1 P07900 7/20 0.34
ACHE P22303 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
NLRP3 Q96P20 1/20 0.33
ALDH1A3 P47895 1/20 0.32
MAPT P10636 2/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TP53 P04637 2/20 0.31
ADORA2A P29274 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TOP1 P11387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2085223 0.84 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL14864090 0.83 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL12964343 0.82 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL12964465 0.77 PDE4A (0.46) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL12964446 0.77 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL12964316 0.76 PDE4A (0.46) PDE4APDE4BPDE4CPDE4DACHE
SCHEMBL12964275 0.76 PDE4A (0.61) PDE4APDE4BPDE4CPDE4DTDP1
SCHEMBL13063206 0.72 PDE4A (0.50) PDE4APDE4BPDE4CPDE4DCYP19A1
SCHEMBL13063204 0.72 PDE4A (0.50) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL12964279 0.72 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863446-B2 Heterocycles ORCHID RESEARCH LABORATORIES LIMITED (IN) 2011-01-04 US disclosed
US-20100329998-A1 NOVEL HETEROCYCLES ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2010-12-30 US disclosed
US-20080207606-A1 Novel heterocycles ORCHID RESEARCH LABORATORIES LIMITED. (IN) 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207606-A1 Novel heterocycles GPR4, UACA, PDE4A PDE4A 3/4885PDE4B 8/4885PDE4C 29/4885
US-20100329998-A1 NOVEL HETEROCYCLES UACA, GPR4, CASP4 PDE4A 4/4885PDE4B 6/4885PDE4C 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.